NR 546 ANTIPSYCHOTICS TABLE WEEK 3 2026
FINAL REVIEW QUESTIONS ANSWERS
BUNDLED PRACTICE COLLECTION
◉ olanzapine (Zyprexa).
Answer: treatment of schizophrenia age 13 and older
Special Comments: Best tolerated antipsychotic
Risk:
High metabolic risk
Highest risk for weight gain, blood dyscrasias, QT prolongation,
cardiovascular disease, cerebrovascular effects, hyperglycemia, and
hyperprolactinemia
◉ quetiapine (Seroquel).
Answer: use for schizophrenia ages 13 and older
Risk:
Moderate metabolic risk
Low EPS risk
,Risk of orthostatic hypotension, blood dyscrasias (neutropenia,
leukopenia, and agranulocytosis), QT prolongation, weight gain, and
renal and hepatic impairment
◉ asenapine (Saphris).
Answer: approved for schizophrenia ages 10 and older
Special Comments: Available in sublingual and transdermal patch
Risk:
Low metabolic risk
◉ clozapine (Clozaril).
Answer: Approved for treatment-resistant schizophrenia and
chronic suicidal behavior in schizophrenia or schizoaffective
disorder
Not indicated in acute presentation of schizophrenia
Special Comments: The Absolute Neutrophil Count (ANC) must be
>1500/mm3 when used and requires initial and weekly monitoring
of WBC, granulocyte, and neutrophil counts.
Risk:
, High metabolic risk
Highest risk for weight gain.
Low EPS risk.
Black box warning: may cause severe neutropenia
Contraindicated in liver disease and hepatic failure
Not a first-choice mediation for treating schizophrenia
◉ Psychosis.
Answer: makes people feel out of control and out of touch with
reality
Antipsychotic meds can help relieve sx
◉ positive symptoms of schizophrenia.
Answer: hallucinations
delusions
Thought disorder
Hostility
Excitability
◉ negative sx of schizophrenia.
Answer: the "A's"
FINAL REVIEW QUESTIONS ANSWERS
BUNDLED PRACTICE COLLECTION
◉ olanzapine (Zyprexa).
Answer: treatment of schizophrenia age 13 and older
Special Comments: Best tolerated antipsychotic
Risk:
High metabolic risk
Highest risk for weight gain, blood dyscrasias, QT prolongation,
cardiovascular disease, cerebrovascular effects, hyperglycemia, and
hyperprolactinemia
◉ quetiapine (Seroquel).
Answer: use for schizophrenia ages 13 and older
Risk:
Moderate metabolic risk
Low EPS risk
,Risk of orthostatic hypotension, blood dyscrasias (neutropenia,
leukopenia, and agranulocytosis), QT prolongation, weight gain, and
renal and hepatic impairment
◉ asenapine (Saphris).
Answer: approved for schizophrenia ages 10 and older
Special Comments: Available in sublingual and transdermal patch
Risk:
Low metabolic risk
◉ clozapine (Clozaril).
Answer: Approved for treatment-resistant schizophrenia and
chronic suicidal behavior in schizophrenia or schizoaffective
disorder
Not indicated in acute presentation of schizophrenia
Special Comments: The Absolute Neutrophil Count (ANC) must be
>1500/mm3 when used and requires initial and weekly monitoring
of WBC, granulocyte, and neutrophil counts.
Risk:
, High metabolic risk
Highest risk for weight gain.
Low EPS risk.
Black box warning: may cause severe neutropenia
Contraindicated in liver disease and hepatic failure
Not a first-choice mediation for treating schizophrenia
◉ Psychosis.
Answer: makes people feel out of control and out of touch with
reality
Antipsychotic meds can help relieve sx
◉ positive symptoms of schizophrenia.
Answer: hallucinations
delusions
Thought disorder
Hostility
Excitability
◉ negative sx of schizophrenia.
Answer: the "A's"
